BioCentury
ARTICLE | Company News

Exelixis Pharmaceuticals Inc., Pharmacia & Upjohn deal

November 8, 1999 8:00 AM UTC

The companies expanded their collaboration focused on the identification of novel targets in Alzheimer's disease and metabolic syndromes to include the use of Exelixis' Mechanism of Action technology ...